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ABSTRACT
Purpose: To evaluate the aesthetic and functional outcomes of autologous fat transfer using the
SEFFI (superficial enhanced fluid fat injection) technique for reconstruction of the periocular
area.
Methods: Autologous fat injections prepared with the 0.5 mL and 0.8 mL SEFFI technique were
used in four patients for periocular rehabilitation.
Results: Case 1 (C1): A patient with left-sided progressive facial hemiatrophy underwent ipsilateral
volumizing with 0.8 SEFFI in the superior, temporal, and inferior periorbital areas, and 0.5 SEFFI in
both eyelids. C2: A 21-year-old female with a post trauma frontal scar, left ptosis, and lower eyelid
retraction was treated with 0.5 SEFFI applied in the scar area associated with an upper eyelid
conjunctivomullerectomy and resection of the lower eyelid retractors. C3: A patient with previous
left-eye evisceration and orbital floor and medial wall fractures underwent socket reconstruction
with buccal mucosal graft in the lower fornix and 0.5 SEFFI injections in both superior and inferior
eyelids. SEFFI was also applied in the intraorbital space for correction of the enophthalmos. C4: A
patient with lower lid retraction post blepharoplasty was treated with 0.8 SEFFI injections in lower
eyelids and malar areas, complemented with a bilateral lateral cantopexy.
Conclusions: Autologous fat transfer with SEFFI technique is an effective and safe procedure in
cases of periocular rehabilitation.
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Restoring a normal and healthy facial appearance after
trauma, progressive disfiguring diseases, surgical, and non
surgical oncologic treatments and unsuccessful cosmetic
surgery present a true challenge for the oculoplastic sur-
geon. More than 120 years ago, Nueber published the first
results with autologous fat transfer for scar
improvement.1 Since then, a therapeutic arsenal including
autologous fat, hyaluronic acid fillers, flaps, grafts, and
more recently mesenchymal stem cells have been devel-
oped trying to overcome the arduous purpose of restoring
a near-to-normal volume, symmetry, skin quality, and
function during periocular reconstruction. Prominent
names of plastic surgery such as Coleman 2 and Rohrich
3, among others, have provided a significant amount of
literature demonstrating the potential of fat grafting for
customized volume increase and facial rejuvenation. In
2015, Bernardini proposed the injection of autologous fat
rich in stem cells at a superficial level pointing out its
regenerative, anti-inflammatory, and immunomodulat-
ing benefits. This technique, SEFFI (superficial enhanced
fluid fat injection), uses 0.5 and 0.8 mLmicro-cannulas in
order to collect fine fat, rich in pluripotent cells.4 We have
expanded the use of SEFFI for periocular rehabilitation
with good results.
Materials and methods
A seven-step standardized protocol, currently used in
our practice, was followed (Table 1). Scar tissue and the
orbicular muscle were injected with 0.5 mL SEFFI, and
0.8 mL SEFFI was used when a more pronounced
volumizing effect was needed. The volume of fat
injected was between 12 and 35 mL (Video).
The selection of the donor site was performed
during the pre-surgical examination. Previous lipo-
suctioned areas were avoided. We prefer the internal
side of the knees and, as a second choice, the abdo-
men, as both provide an easy access.
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In the periocular area, fat filling was performed
using a retrograde injection technique (to prevent real
risk of fat embolism) exerting the least possible pres-
sure. Five cc 0.5 mL SEFFI syringes with 23G needles
and 5 cc 0.8 mL SEFFI syringes with 20G needles were
used 4
The results were subjectively evaluated both by sur-
geons and patients using standardized photographic
exams (Canon® EOS Rebel T3i with 60 mm lens,
Tokyo, Japan) pre- and post- intervention with a mini-
mum follow-up of 6 months. Written consent was
obtained from all identifiable patients.
Results
C1: A 29-year-old female patient with Parry
Romberg Syndrome (Figure 1a). A total of 24 mL
of 0.8 SEFFI was used in the left superior, temporal,
and inferior periorbital areas. The eyelids were trea-
ted with 6 mL of 0.5 SEFFI (Figure 1b). A satisfac-
tory improvement was obtained at 1 year of follow-
up (Figure 1c).
C2: A 21-year-old female patient with left ptosis,
lower lid retraction, and a prominent frontal scar
resulting from a previous motor vehicle accident
was referred to our clinic (Figure 2a). The scar area
was treated with 6 cc of 0.5 SEFFI, and a left con-
junctivomullerectomy combined with left lower eye-
lid retractors resection were used to treat the ptosis
and lower eyelid retraction, respectively (Figure 2b).
A good result was obtained 6 months after surgery
(Figure 2c).
C3: A 36-year-old female patient with previous left-
eye evisceration and left orbital floor and medial wall
fractures was evaluated due to enophthalmos
(Figure 3a). Socket reconstruction was performed
Figure 1. Parry Romberg Syndrome.
Table 1. Autologous fat transfer technique.
(1) Anesthesia
Under sterile technique, at the same time as facial anesthesia
Donor site marking
Local anesthesia: 500 mL saline solution + 20 mL 2% lidocaine + 1 mL 1:1000 epinephrine
Stab incision with 11 blade. Inject local with 20 mL syringe and 2 mm diameter cannula
20 mL in deep fat, 20 mL in superficial fat. Wait 15 min for vasoconstriction
(2) Harvesting
Fat is suctioned with SEFFI cannulas (0.5 and 0.8 mm side ports) using 10 mL syringes
Not exceed 2 cc of negative pressure to suck
The volume of fat harvested is twice the amount needed for injection
Donor site does not need suturing
(3) Centrifugation
Each syringe is placed on a sterile tube in the centrifuge
Fat is centrifuged 3 min at 3000 rpm
(4) Processing
The infranatant (blood + local) is discarded
Supernatant (oil) is also discarded
(5) Platelet rich plasma (PRP)
20 mL of blood is withdrawn in 2 citrated tubes and centrifuged 2 min at 1000 rpm
PRP is mixed with the processed fat in a volume of 20% of the volume of the fat
(6) Injection
Fat + PRP is transferred to 5 mL syringes
Injection is performed in a superficial level using 21 G needles or intraorbital with cannula
(7) Donor site care
A small patch is applied to the entry point
Compressive bandages are applied


























Figure 2. Scar from a previous motor vehicle accident.



























using a buccal mucosal graft on the lower fornix, and
4 mL of 0.5 SEFFI were injected into the upper lid, 3
mL to the lower lid, and 5 mL into the intraorbital
space using an inferotemporal transpalpebral
approach. At 1 year follow-up, a good improvement
was noticed (Figure 3b).
Case 4: A 43-year-old male patient was evaluated for
lower lid retraction post blepharoplasty (Figure 4a). We
used 10 mL of 0.8 SEFFI in each lower eyelid and malar
region, associated with a bilateral lateral cantopexy. A
satisfactory result was obtained after 1 year of follow-up
(Figure 4b).
Discussion
In this report, we describe four illustrative cases of our
experience with SEFFI from a total of 20 reconstructive
cases. The use of autologous fat transfer for facial
rejuvenation is a well-accepted and largely widespread
procedure. 2–4 Recent advances in cell therapy have
highlighted the adipose tissue-derived stem cells
(ASCs) potential, leading to the concept of enriched
lipotransfer, containing higher quantities of these plur-
ipotent cells, with proven benefits.5
We have started to expand the SEFFI technique to
non-purely aesthetic indications with encouraging
results. As the management of such cases should first
take into account the primary need of each situation,
the quantity and place of injection are individually
adjustable. In the treatment of disfiguring scars, the
transfer of micro-fat rich in ASCs, such as SEFFI, offers
great advantages, since the main purpose is tissue
regeneration.6 When the loss of substance is a major
concern (such as in cases 1,3,4), the goal should be
double, and volume restoration should be complemen-
ted with elements that might improve the microenvir-
onment around the fat graft. This is more easily
achieved with a micro-transfer technique such as
SEFFI, rich in trophic and immunomodulatory factors,
than with previous macro-transfer procedures.
In our clinical practice, SEFFI has proven to be effec-
tive in sculpturing target areas in a homogeneous and
long-term predictable way, addressing volume concerns
and also improving skin appearance. We can therefore
highlight several advantages of this method compared to
Coleman’s harvesting technique using 2-mm side-port
cannulae and other macro-grafting procedures. In addi-
tion to being enriched with ASCs as mentioned, SEFFI
harvesting is made with “micro” side-port cannulae that
obviate other fat processing; it is enhanced with platelet-
rich plasma and is easily manipulated and injected using
syringe needles. All these features make SEFFI an excel-
lent alternative in reconstructive cases.
Platelet-rich plasma is an autologous concentration
of platelets in a small volume of plasma. A pilot study
demonstrated that mixing platelet-rich plasma with fat
improves the fat’s survival when injected in rats,
increases vascularization, and produces fewer cysts,
vacuoles, and fibrosis.7 Besides improving the survival
and quality of the fat graft, it helps the graft to be more
fluid, therefore avoiding the obstruction of the syringe
at the time of injection.4 In our experience fat injection
without PRP is much more difficult due to repeated
needle blockage. In all cases, we used a centrifugation
velocity of 1,000 rpm during 2 minutes, as a slower
centrifugation better preserves the components.8
We found difficult to manage cases of post surgical
unequal distribution and irregularity (formation of
nodules), mainly observed after 0.5 mL SEFFI injec-
tions in the eyelids, where the skin is typically thinner.
We believe that the recently published micro-superficial
enhanced fluid fat injection (M-SEFFI) technique,
using the 0.3 mL multi-perforated cannula, will signifi-
cantly avoid this complication.9 We did not have any
Figure 4. Lower lid retraction post blepharoplasty.


























case of fat embolism after injecting the periocular area;
however, we are aware of this potential risk.
We hope this report will open a new insight on
autologous fat transfer use. Even though the use of fat
in reconstructive surgery is not a new concept, we are
now attempting to expand all the proven SEFFI benefits
to the reconstructive field. We emphasize, however, that
a higher number of cases, longer follow-up and the use
of objective volumetric measures are still needed in
order to definitely improve our understanding of the
long-term results and potential of this procedure.
Conclusion
Lipotransfer with the SEFFI technique is an effective
and safe procedure in cases of periocular and orbital
rehabilitation.
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